The registry will follow 1,500 patients worldwide for five years from the date of their first liver ablation procedure with the company's NEUWAVE System.
Johnson & Johnson Medical Devices Companies04.01.19
Auris' robotic platform is currently used in bronchoscopic diagnostic and therapeutic procedures; J&J hopes to expand to other interventional applications.